Skip to primary content
Skip to secondary content

PHC Primary Care Blog

Partnership HealthPlan of California

PHC Primary Care Blog

Main menu

  • Home
  • About Us
  • Contact Us

Category Archives: Formulary & Pharmacy Issues

Post navigation

← Older posts
Newer posts →

Statins vary in side effect profile

Posted on July 10, 2013 by RMoore

Statins as a drug class are generally safe and widely used to treat hyperlipidemia. They have proven effective in lowering cholesterol levels and reducing the risk of recurrent cardiovascular events in patients at risk.

There are also some concerns about Continue reading →

Posted in Formulary & Pharmacy Issues, Medical Practice, Prevention

The most powerful treatment we have

Posted on June 18, 2013 by RMoore

Case Study: A primary care clinician recently diagnosed a patient with major depression. She prescribed citalopram 20 mg per day. One month later the patient felt less depressed and her PHQ-9 had dropped from 16 (moderate depression) to Continue reading →

Posted in Formulary & Pharmacy Issues, Medical Practice

To prophylax or not to prophylax – that is and remains the question for total joint patients

Posted on April 29, 2013 by RMoore

Physicians pride themselves on taking a scientific, evidence-based approach to therapeutic questions. Unfortunately, in many clinical situations the evidence is scant or limited. One common and thorny situation is whether to give antibiotic prophylaxis to total joint Continue reading →

Posted in Formulary & Pharmacy Issues, Medical Practice, Prevention

CURING our prescription drug abuse ills

Posted on April 23, 2013 by RMoore

The California State Senate Business and Professions Committee recently passed out of committee SB 809, a measure which will levy a 1.2% license fee for pharmacists, NPs, physicians, and podiatrists to increase funding for the Continue reading →

Posted in Chronic Pain, Formulary & Pharmacy Issues, Health Care Reform & Health Policy, Medical Practice

Trapped between a rock (calcium carbonate) and a hard place (endovascular plaque)

Posted on February 19, 2013 by RMoore

Once again the issue of too much calcium intake rears its ugly head. This time it comes up in a prospective cohort study looking at all-cause, cardiovascular, ischemic heart disease, and stroke mortality. High intake of calcium in women was associated with Continue reading →

Posted in Formulary & Pharmacy Issues, Prevention

Osteoporosis: tips on screening and treatment

Posted on January 7, 2013 by RMoore

I don’t know about you, but I find osteoporosis frustrating. So many questions. When and who should I screen? When and who should I re-screen? How concerned should I be about possible side effects of various bisphosphonates? Are calcium Continue reading →

Posted in Formulary & Pharmacy Issues, Prevention

A look at medications for diabetic neuropathy

Posted on January 2, 2013 by RMoore

“You become responsible, forever, for what you have tamed.”  – The Little Prince, Antoine de Saint Exupery.

In the treatment of peripheral neuropathy, Partnership HealthPlan of California’s formulary has step requirements. It begins with Continue reading →

Posted in Chronic Pain, Formulary & Pharmacy Issues

“If evolution really works, how come mothers only have two hands?”

Posted on December 20, 2012 by RMoore

Okay, this quote from Milton Berle is only tangentially related to today’s blog post, but I couldn’t pass it up. My last contribution to our blog was on rising mortality due to Clostridia difficile (C.diff) and its fomite- and hand-related transmission. Continue reading →

Posted in Formulary & Pharmacy Issues, Prevention

“I don’t want to hold your hand.” – C.S.Lewis. “I want to hold your hand.” – The Beatles

Posted on December 18, 2012 by RMoore

A recent survey of multiple large, national databases in the US has reported that Clostridium difficile (C.diff) colitis is now the 9th leading cause of gastrointestinal and liver related deaths. Way out of line with my own perception of GI-related mortality, Continue reading →

Posted in Formulary & Pharmacy Issues, Prevention, Uncategorized

Pneus on pneumococcal vaccination from the ACIP

Posted on October 31, 2012 by RMoore

The CDC Advisory Committee on Immunization Practices (ACIP) has just changed its recommendations for the use of pneumococcal vaccines for adults 19 years or older with immunocompromising conditions, such as functional or anatomic asplenia, Continue reading →

Posted in Formulary & Pharmacy Issues, Prevention

Post navigation

← Older posts
Newer posts →

Subscribe To Our Feed to easily keep up with new posts & comments

  • RSS - Posts
  • RSS - Comments

Register for the blog

  • Register
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Recent Posts

  • Challenges of Thinking Like a Scientist
  • Scheduling Well-Child Visits: Taking Demand for Acute Visits into Account
  • Preparing Our Staff for Emergencies
  • Statewide Implementation of Justice-Involved Health Care Transitions
  • Difficult, but Rewarding, Conversations

Recent Comments

    Archives

    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • May 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • September 2024
    • August 2024
    • July 2024
    • May 2024
    • March 2024
    • February 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • June 2022
    • May 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2019
    • October 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018
    • December 2017
    • October 2017
    • September 2017
    • August 2017
    • July 2017
    • June 2017
    • May 2017
    • April 2017
    • March 2017
    • February 2017
    • January 2017
    • December 2016
    • November 2016
    • October 2016
    • September 2016
    • August 2016
    • July 2016
    • June 2016
    • May 2016
    • April 2016
    • March 2016
    • February 2016
    • January 2016
    • December 2015
    • November 2015
    • October 2015
    • September 2015
    • August 2015
    • July 2015
    • June 2015
    • May 2015
    • April 2015
    • March 2015
    • February 2015
    • January 2015
    • December 2014
    • November 2014
    • October 2014
    • September 2014
    • August 2014
    • July 2014
    • June 2014
    • May 2014
    • April 2014
    • March 2014
    • February 2014
    • January 2014
    • December 2013
    • November 2013
    • October 2013
    • September 2013
    • August 2013
    • July 2013
    • June 2013
    • May 2013
    • April 2013
    • March 2013
    • February 2013
    • January 2013
    • December 2012
    • November 2012
    • October 2012
    • September 2012
    • August 2012
    • July 2012
    • June 2012
    • May 2012
    • April 2012
    • March 2012
    • February 2012

    Categories

    • Access/Practice Innovation
    • Advance Care Planning/End of Life Care
    • Asthma
    • Chronic Pain
    • COPD
    • Drug and Substance Abuse
    • Formulary & Pharmacy Issues
    • Health Care Reform & Health Policy
    • Immunization
    • Medical Practice
    • Mental Health Issues
    • Pediatrics
    • PHC Services
    • Prevention
    • QIP
    • Social and Societal Aspects of Medicine
    • Specialists
    • Uncategorized
    Proudly powered by WordPress